ID
45858
Descrição
Principal Investigator: Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001018 We performed comprehensive molecular profiling of renal tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of response and resistance to existing and emerging therapies in this disease, as well as mechanisms of tumor evolution in the context of treatment.
Link
Palavras-chave
Versões (1)
- 08/10/2023 08/10/2023 - Simon Heim
Titular dos direitos
Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
Transferido a
8 de outubro de 2023
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs001018 Molecular Characterization of Clinical Renal Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
C0680251 (UMLS CUI [1,2])
C0740457 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0475358 (UMLS CUI [1,4])
C3845275 (UMLS CUI [1,5])